Angel Fund representatives Founding Director Eugene Nigro (left), President Rich Kennedy (second from left), and Director Dr. Neil Gleason (right) presented the donation to Jennifer DeMartino, Lead, ALS Patient, Family & Community Engagement Sean M. Healey & AMG Center for ALS (third from left); Dr. Jenn Morganroth, (third from right), a principal investigator at the Sean M. Healey & AMG Center for ALS; and Dr. James Berry, MD, MPH, (second from right), Chief of the Division of ALS and Motor Neuron Diseases at Mass General Brigham.

The Angel Fund for ALS Research recently presented $400,000 to the Sean M. Healey & AMG Center for ALS to support research into the use of a new technology platform for identifying novel biomarkers. The funds will support Drs. Berry’s research to identify novel biomarkers of ALS onset in genetically at-risk participants from the Dominantly Inherited ALS (DIALS) study. Biosamples will be analyzed using the Nucleic acid-Linked Immuno-Sandwich Assay (NULISA) platform, a new technology that can detect protein biomarkers.